glp 1 drugs and ulcerative colitis SAFETY CLINICAL EFFECTIVENESS OF GLP1 AGONISTS IN INFLAMMATORY BOWEL DISEASE PATIENTS Relevance of Glucagon-Like Peptide 1

Current GLP-1 therapies (Ozempic/semaglutide, dulaglutide, liraglutide) require: Refrigeration and cold-chain storage Subcutaneous injections (compliance issues) Complex, expensive manufacturing Restrictive dosing (oral semaglutide: overnight fasting, 30-min wait before eating) All prior candidates failed due to poor potency or inadequate pharmacokinetics ( 3,100 adults with obesity (without diabetes)

During your off-cycle, support recovery and hormone balance with ZMT , DHEA , or GH secretagogues like GHRP2 or CJC1295

Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis

Mol Ther 25(10):24042414